Roche provides update on tominersen programme in manifest Huntington’s disease
Dosing to stop in Phase III clinical study of tominersen following recommendation from an Independent Data ...
Read more
Tag: Huntington’s disease
Dosing to stop in Phase III clinical study of tominersen following recommendation from an Independent Data ...
Read more